New Targeted Chemotherapy Technology Proves Effective in Mice

Compound Can be Administered at 50x Higher Doses and Effectively Shrinks Tumors with Few Side Effects in Mouse Tests

Good Advice Makes The Difference: Catalyst Program Pairs UCSF Scientists With Expert Advisors

Highlights of Spring 2016 Catalyst Final Report Out

Virtually Biotechs

Why early stage academic deals are heating up

Lawmaker Wants to Fund More UC Innovation

Expanding Entrepreneurship at UCSF - QB3, Catalyst, ITA

UCSF Researchers Win Awards to Bring Treatments Out of Lab

Promising early stage research highlighted at Fall 2015 Catalyst Awards cycle event

MedImmune Announces Research Collaboration with UCSF Catalyst

Top scientists partner to research the progression and biology of RIA diseases

Eye Drops Could Clear Up Cataracts Using Newly Identified Chemical

Latest research published by UCSF-CTSI Catalyst Award winner

Data Reproducibility in Preclinical Research and Discovery

A panel of experts discusses issues surrounding data reproducibility and upcoming changes to NIH requirements.

Sigma-Aldrich Announces Strategic Collaboration with Catalyst Program

Sigma-Aldrich Corporation Signs Agreement to Support Catalyst Program Research Efforts

UCSF Innovation Partners Collaborate to Accelerate Promising Research

Promising early stage research highlighted at Spring 2015 Catalyst Awards event.